BACKGROUND: Resistin, a recently discovered hormone, is purportedly involved in metabolic and inflammatory processes in humans and may thus be an important marker to assess disease risk in large-scale epidemiological studies. METHODS: We assessed the reliability of human resistin levels in 63 men and 51 women aged 35-67 years with repeated measurements of resistin over a period of 1 year. Student's paired t-test was used to compare resistin concentrations at baseline and 1 year later. Intraclass correlation coefficients (ICCs) were calculated by analysis of variance. RESULTS: There was no significant difference between resistin concentrations at baseline and after 1 year for both sexes combined or when analyzed separately for men and women. The ICCs were 0.70 (95% CI 0.59-0.78) for both sexes combined, 0.75 (95% CI 0.62-0.84) for men, and 0.66 (95% CI 0.47-0.79) for women. Resistin levels were not significantly related to age, body mass index, waist-to-hip ratio, sex, or fasting status. CONCLUSIONS: Individual blood resistin concentrations did not significantly change over a period of 1 year, but showed a high degree of reliability. Our findings suggest that a single resistin measurement may be sufficient for risk assessment in epidemiological studies.
No takes yet. Share an insight, caveat, or question.
Weikert et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: